Kintara Therapeutics Inc (KTRA)

[Jumpinjackas]

Maxim contradicts your statement. This make sense why the price has been falling off the cliff. Also, this is why they only have one site thus far.:


In a rarity for uber-bull Maxim Group, it downgrades DelMar Pharmaceuticals (DMPI -2.1%) to Hold citing doubts about its ability to raise sufficient capital to advance lead candidate VAL-083, positioned to enter Phase 3 development in treatment-resistant brain cancer. It adds that management was hopeful that warrant exercises would raise an additional $10M in cash, but with exercise prices from $3.00 - 3.50 and the stock languishing at $1.40, this appears to be a remote near-term possibility


So, I see another funding here soon and it won't be pretty if the price stays here, which I see it doing.